KoBioLabs, Inc (KOSDAQ:348150)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,440.00
-510.00 (-8.57%)
At close: Apr 2, 2026

KoBioLabs Revenue

In the year 2025, KoBioLabs had annual revenue of 69.29B KRW with 1.36% growth. KoBioLabs had revenue of 15.12B in the quarter ending December 31, 2025, a decrease of -14.36%.

Revenue
69.29B
Revenue Growth
+1.36%
P/S Ratio
1.67
Revenue / Employee
n/a
Employees
n/a
Market Cap
115.54B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202569.29B932.96M1.36%
Dec 31, 202468.36B35.22B106.28%
Dec 31, 202333.14B21.53B185.54%
Dec 31, 202211.61B8.71B301.12%
Dec 31, 20212.89B-1.70B-36.98%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
CTCBIO123.77B
Cell Biotech53.13B
CORESTEMCHEMON20.13B
BIO-FD&C18.82B
QuadMedicine13.11B
TegoScience5.94B
Quratis2.46B
NovMetaPharma1.30B
Revenue Rankings